US Stock MarketDetailed Quotes

ABUS Arbutus Biopharma

Watchlist

3.290
+0.020+0.61%

Close Jan 2 16:00 ET

623.43MMarket Cap-7.65P/E (TTM)

Arbutus Biopharma Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q3)Sep 30, 2024

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

Total revenue

-71.25%1.34M

-62.89%1.73M

-77.09%1.53M

-53.51%18.14M

-65.65%2.15M

-21.74%4.66M

-67.34%4.65M

-46.85%6.69M

255.11%39.02M

94.79%6.25M

Operating revenue

-71.25%1.34M

-62.89%1.73M

-77.09%1.53M

-53.51%18.14M

-65.65%2.15M

-21.74%4.66M

-67.34%4.65M

-46.85%6.69M

255.11%39.02M

94.79%6.25M

Cost of revenue

Gross profit

Operating expense

-27.68%18.81M

-2.42%23.1M

-13.06%20.72M

-5.93%96.18M

-16.67%22.67M

10.46%26.01M

-15.88%23.67M

2.03%23.83M

23.72%102.24M

14.23%27.2M

Selling and administrative expenses

-22.34%4.54M

26.20%7.55M

-4.32%5.31M

26.02%22.48M

20.05%5.1M

67.25%5.84M

15.00%5.98M

13.49%5.55M

4.07%17.83M

-7.57%4.25M

-General and administrative expense

-22.34%4.54M

26.20%7.55M

-4.32%5.31M

26.02%22.48M

20.05%5.1M

67.25%5.84M

15.00%5.98M

13.49%5.55M

4.07%17.83M

-7.57%4.25M

Research and development costs

-29.23%14.27M

-12.10%15.55M

-15.72%15.4M

-12.69%73.7M

-23.47%17.56M

0.57%20.17M

-22.88%17.69M

-1.01%18.28M

28.86%84.41M

19.45%22.95M

Operating profit

18.18%-17.47M

-12.36%-21.37M

-11.92%-19.18M

-23.43%-78.03M

2.07%-20.52M

-21.35%-21.35M

-36.83%-19.02M

-59.10%-17.14M

11.76%-63.22M

-1.70%-20.95M

Net non-operating interest income expense

18.65%1.72M

39.15%1.8M

40.28%1.5M

1,022.10%5.23M

124.13%1.42M

446.42%1.45M

1,600.00%1.29M

408.36%1.07M

117.07%466K

219.62%634K

Non-operating interest income

16.93%1.75M

25.19%1.83M

21.85%1.55M

159.49%5.69M

55.36%1.47M

115.27%1.49M

268.94%1.46M

697.48%1.27M

1,625.98%2.19M

3,043.33%943K

Non-operating interest expense

-36.96%29K

-80.12%34K

-77.78%44K

-73.41%459K

-85.76%44K

-89.28%46K

-64.52%171K

-60.87%198K

-39.59%1.73M

-44.82%309K

Other net income (expense)

-1,891.96%-3.96M

-134.38%-219K

28.25%-193K

98.05%-44K

86.79%-213K

15.68%-199K

410.73%637K

-33.83%-269K

-20.78%-2.26M

-757.98%-1.61M

Gain on sale of security

-16.67%5K

-900.00%-8K

-425.00%-13K

213.64%25K

450.00%14K

128.57%6K

-66.67%1K

--4K

-540.00%-22K

---4K

Special income (charges)

-1,836.10%-3.97M

-133.18%-211K

34.07%-180K

96.91%-69K

85.89%-227K

4.65%-205K

405.77%636K

-35.82%-273K

-19.28%-2.23M

-733.68%-1.61M

-Less：Restructuring and merger&acquisition

1,836.10%3.97M

133.18%211K

-34.07%180K

-96.91%69K

-85.89%227K

-4.65%205K

-405.77%-636K

35.82%273K

19.28%2.23M

733.68%1.61M

Income before tax

1.92%-19.72M

-15.81%-19.8M

-9.40%-17.88M

-12.05%-72.85M

11.95%-19.31M

-14.44%-20.1M

-20.45%-17.09M

-44.32%-16.34M

14.74%-65.01M

-2.87%-21.93M

Income tax

4.44M

Net income

1.92%-19.72M

-15.81%-19.8M

-9.40%-17.88M

-4.89%-72.85M

11.95%-19.31M

-14.44%-20.1M

-20.45%-17.09M

-3.64%-16.34M

8.91%-69.46M

-2.87%-21.93M

Net income continuous Operations

1.92%-19.72M

-15.81%-19.8M

-9.40%-17.88M

-4.89%-72.85M

11.95%-19.31M

-14.44%-20.1M

-20.45%-17.09M

-3.64%-16.34M

8.91%-69.46M

-2.87%-21.93M

Minority interest income

Net income attributable to the parent company

1.92%-19.72M

-15.81%-19.8M

-9.40%-17.88M

-4.89%-72.85M

11.95%-19.31M

-14.44%-20.1M

-20.45%-17.09M

-3.64%-16.34M

8.91%-69.46M

-2.87%-21.93M

Preferred stock dividends

Other preferred stock dividends

Net income attributable to common stockholders

1.92%-19.72M

-15.81%-19.8M

-9.40%-17.88M

-4.89%-72.85M

11.95%-19.31M

-14.44%-20.1M

-20.45%-17.09M

-3.64%-16.34M

21.42%-69.46M

-0.17%-21.93M

Basic earnings per share

16.67%-0.1

-10.00%-0.11

0.00%-0.1

4.35%-0.44

14.29%-0.12

0.00%-0.12

0.00%-0.1

9.09%-0.1

44.58%-0.46

6.67%-0.14

Diluted earnings per share

16.67%-0.1

-10.00%-0.11

0.00%-0.1

4.35%-0.44

14.29%-0.12

0.00%-0.12

0.00%-0.1

9.09%-0.1

44.58%-0.46

6.67%-0.14

Dividend per share

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(Q3)Sep 30, 2024	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022
Total revenue	-71.25%1.34M	-62.89%1.73M	-77.09%1.53M	-53.51%18.14M	-65.65%2.15M	-21.74%4.66M	-67.34%4.65M	-46.85%6.69M	255.11%39.02M	94.79%6.25M
Operating revenue	-71.25%1.34M	-62.89%1.73M	-77.09%1.53M	-53.51%18.14M	-65.65%2.15M	-21.74%4.66M	-67.34%4.65M	-46.85%6.69M	255.11%39.02M	94.79%6.25M
Cost of revenue
Gross profit
Operating expense	-27.68%18.81M	-2.42%23.1M	-13.06%20.72M	-5.93%96.18M	-16.67%22.67M	10.46%26.01M	-15.88%23.67M	2.03%23.83M	23.72%102.24M	14.23%27.2M
Selling and administrative expenses	-22.34%4.54M	26.20%7.55M	-4.32%5.31M	26.02%22.48M	20.05%5.1M	67.25%5.84M	15.00%5.98M	13.49%5.55M	4.07%17.83M	-7.57%4.25M
-General and administrative expense	-22.34%4.54M	26.20%7.55M	-4.32%5.31M	26.02%22.48M	20.05%5.1M	67.25%5.84M	15.00%5.98M	13.49%5.55M	4.07%17.83M	-7.57%4.25M
Research and development costs	-29.23%14.27M	-12.10%15.55M	-15.72%15.4M	-12.69%73.7M	-23.47%17.56M	0.57%20.17M	-22.88%17.69M	-1.01%18.28M	28.86%84.41M	19.45%22.95M
Operating profit	18.18%-17.47M	-12.36%-21.37M	-11.92%-19.18M	-23.43%-78.03M	2.07%-20.52M	-21.35%-21.35M	-36.83%-19.02M	-59.10%-17.14M	11.76%-63.22M	-1.70%-20.95M
Net non-operating interest income expense	18.65%1.72M	39.15%1.8M	40.28%1.5M	1,022.10%5.23M	124.13%1.42M	446.42%1.45M	1,600.00%1.29M	408.36%1.07M	117.07%466K	219.62%634K
Non-operating interest income	16.93%1.75M	25.19%1.83M	21.85%1.55M	159.49%5.69M	55.36%1.47M	115.27%1.49M	268.94%1.46M	697.48%1.27M	1,625.98%2.19M	3,043.33%943K
Non-operating interest expense	-36.96%29K	-80.12%34K	-77.78%44K	-73.41%459K	-85.76%44K	-89.28%46K	-64.52%171K	-60.87%198K	-39.59%1.73M	-44.82%309K
Other net income (expense)	-1,891.96%-3.96M	-134.38%-219K	28.25%-193K	98.05%-44K	86.79%-213K	15.68%-199K	410.73%637K	-33.83%-269K	-20.78%-2.26M	-757.98%-1.61M
Gain on sale of security	-16.67%5K	-900.00%-8K	-425.00%-13K	213.64%25K	450.00%14K	128.57%6K	-66.67%1K	--4K	-540.00%-22K	---4K
Special income (charges)	-1,836.10%-3.97M	-133.18%-211K	34.07%-180K	96.91%-69K	85.89%-227K	4.65%-205K	405.77%636K	-35.82%-273K	-19.28%-2.23M	-733.68%-1.61M
-Less：Restructuring and merger&acquisition	1,836.10%3.97M	133.18%211K	-34.07%180K	-96.91%69K	-85.89%227K	-4.65%205K	-405.77%-636K	35.82%273K	19.28%2.23M	733.68%1.61M
Income before tax	1.92%-19.72M	-15.81%-19.8M	-9.40%-17.88M	-12.05%-72.85M	11.95%-19.31M	-14.44%-20.1M	-20.45%-17.09M	-44.32%-16.34M	14.74%-65.01M	-2.87%-21.93M
Income tax				0					4.44M	0
Net income	1.92%-19.72M	-15.81%-19.8M	-9.40%-17.88M	-4.89%-72.85M	11.95%-19.31M	-14.44%-20.1M	-20.45%-17.09M	-3.64%-16.34M	8.91%-69.46M	-2.87%-21.93M
Net income continuous Operations	1.92%-19.72M	-15.81%-19.8M	-9.40%-17.88M	-4.89%-72.85M	11.95%-19.31M	-14.44%-20.1M	-20.45%-17.09M	-3.64%-16.34M	8.91%-69.46M	-2.87%-21.93M
Minority interest income
Net income attributable to the parent company	1.92%-19.72M	-15.81%-19.8M	-9.40%-17.88M	-4.89%-72.85M	11.95%-19.31M	-14.44%-20.1M	-20.45%-17.09M	-3.64%-16.34M	8.91%-69.46M	-2.87%-21.93M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders	1.92%-19.72M	-15.81%-19.8M	-9.40%-17.88M	-4.89%-72.85M	11.95%-19.31M	-14.44%-20.1M	-20.45%-17.09M	-3.64%-16.34M	21.42%-69.46M	-0.17%-21.93M
Basic earnings per share	16.67%-0.1	-10.00%-0.11	0.00%-0.1	4.35%-0.44	14.29%-0.12	0.00%-0.12	0.00%-0.1	9.09%-0.1	44.58%-0.46	6.67%-0.14
Diluted earnings per share	16.67%-0.1	-10.00%-0.11	0.00%-0.1	4.35%-0.44	14.29%-0.12	0.00%-0.12	0.00%-0.1	9.09%-0.1	44.58%-0.46	6.67%-0.14
Dividend per share
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	--	--	--	--	--	--	--	Unqualified Opinion	--

Heat List

Overall

No Data